Lam's AI-Led Growth Contrasts with Escalating China Risks and High Valuation

What happened

Lam Research is capitalizing on the AI-driven semiconductor boom, with significant capex and headcount expansion to meet surging demand from foundries like TSMC, as highlighted in a recent bullish article. Operational improvements have driven non-GAAP operating margins to around 34% in recent quarters, aligning with the article's claims of margin growth from 24% to 33.9%. However, DeepValue's filings-based analysis reveals that China revenue exposure increased to 39% in 1H FY26 from 34% in FY25, amplifying risks from export controls that have already imposed a $600M headwind for FY26. Deferred revenue declined from $2.7B to $2.25B, indicating potential demand timing issues and reduced near-term visibility. The stock trades at elevated multiples of 47.7x P/E and 46.0x EV/EBITDA, pricing in sustained growth while overlooking these structural vulnerabilities.

Implication

The optimistic narrative around AI-driven demand is already embedded in Lam's stock price, leaving limited upside without clear de-risking from China exposure, which now accounts for 39% of revenue. Export controls present a tangible threat, with a quantified $600M impact for FY26 and potential for further tightening that could compress margins and stall growth. Declining deferred revenue signals weakening customer commitments, raising concerns about earnings stability and the conversion of future orders. Management's aggressive buybacks and operational efficiency provide some buffer but do not address the core geopolitical concentration risk that could trigger multiple contraction. Therefore, investors should await either a valuation reset toward $200 or evidence that non-China demand can sustainably offset these headwinds before considering a position.

Thesis delta

The new article's emphasis on growth and margin improvement does not shift the fundamental thesis, as these positives are already reflected in Lam's high valuation and are countered by rising China risks highlighted in the filings. The report's WAIT rating remains valid, as the need for proof that non-China demand can offset geopolitical overhangs and deferred revenue conversion stays critical. Thus, the investment call is unchanged, with the article serving as a reminder of short-term momentum rather than altering the long-term risk profile.